EP2187743
Rapamycin formulations for treatment of age related macular degeneration
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
18.8.2008EP published:
30.7.2014EP application number:
08827362.8
EPO information:
European Patent Register
Max expiry date:
17.8.2028
Title:
Rapamycin formulations for treatment of age related macular degeneration
Timeline
Today
18.8.2008EP application
30.7.2014EP Publication
Owner
Name:
Santen Pharmaceutical Co., LtdAddress:
9-19, Shimoshinjo 3-chome Higashiyodogawa-ku, 533-8651, Osaka, JP
Inventor
Name:
DOR, Philippe, JmAddress:
Union City, CA, US
Name:
MUDUMBA, SreenivasuAddress:
Union City, CA, US
Name:
NIVAGGIOLI, ThierryAddress:
Union City, CA, US
Name:
WEBER, David, A.Address:
Union City, CA, US
Name:
FAROOQ, SidiqAddress:
Union City, CA, US
Name:
TAKHAR, Sudeep, KaurAddress:
Union City, CA, US
Priority
Number:
965282 PDate:
16.8.2007Country:
US
Number:
965258 PDate:
16.8.2007Country:
US
Classification
Categories:
A61K 9/00, A61K 31/4184, A61K 31/575, A61K 39/395, A61P 27/02